BAKER BROS. ADVISORS LP Q3 2019 Filing

Filed November 14, 2019

Portfolio Value

$14.7B

Holdings

109

Report Date

Q3 2019

Filing Type

13F-HR

All Holdings (109 positions)

StockValue
SGENEURSeattle Genetics, Inc.
$4.3B
INCYIncyte Corporation
$2.4B
ACADACADIA Pharmaceuticals Inc.
$1.5B
ONCBeiGene, Ltd.
$1.4B
ALXNAlexion Pharmaceuticals, Inc.
$808.8M
AMRNAmarin Corporation plc
$629.8M
Genomic Health, Inc.
$627.0M
BMRNBioMarin Pharmaceutical Inc.
$511.5M
ASNDAscendis Pharma A/S
$326.6M
NVTA1EURInvitae Corporation
$169.4M
KODKodiak Sciences Inc.
$131.5M
NBIXNeurocrine Biosciences, Inc.
$127.5M
ARGXargenx SE
$116.2M
HRTXHeron Therapeutics, Inc.
$111.3M
MRTXEURMirati Therapeutics, Inc.
$101.8M
MDGLMadrigal Pharmaceuticals, Inc.
$100.8M
MyoKardia, Inc.
$79.1M
Spark Therapeutics, Inc.
$72.9M
1T7Tricida, Inc.
$60.8M
RYTMRhythm Pharmaceuticals, Inc.
$58.5M
1K0IGM Biosciences, Inc.
$55.8M
Ra Pharmaceuticals, Inc.
$55.5M
CERSCerus Corporation
$55.4M
DBV Technologies S.A.
$47.4M
Principia Biopharma Inc.
$46.7M
BCELAtreca, Inc.
$43.2M
GW Pharmaceuticals plc
$42.7M
Zymeworks Inc.
$42.4M
Audentes Therapeutics, Inc.
$42.3M
NBIX 2.25 05/15/24Neurocrine Biosciences, Inc.
$42.1M
IM8NInsmed Incorporated
$39.3M
BCRXBioCryst Pharmaceuticals, Inc.
$36.5M
ADPTAdaptive Biotechnologies Corporation
$36.0M
KRYSKrystal Biotech, Inc.
$35.9M
Neoleukin Therapeutics, Inc.
$32.2M
CBAYUSDCymaBay Therapeutics, Inc.
$29.2M
ALLKGUSDAllakos Inc.
$26.7M
KNSAKiniksa Pharmaceuticals, Ltd.
$23.8M
MRUSMerus N.V.
$20.7M
QUREuniQure N.V.
$20.4M
URGNUroGen Pharma Ltd.
$17.8M
AXSMAxsome Therapeutics, Inc.
$15.6M
BMRN 0.599 08/01/24BioMarin Pharmaceutical Inc.
$14.7M
XNCRXencor, Inc.
$14.4M
Aimmune Therapeutics, Inc.
$14.1M
PTGXProtagonist Therapeutics, Inc.
$14.1M
La Jolla Pharmaceutical Company
$13.7M
Idera Pharmaceuticals, Inc.
$13.3M
AGLEUSDAeglea BioTherapeutics, Inc.
$13.2M
ALKSAlkermes plc
$12.2M
Syros Pharmaceuticals, Inc.
$10.1M
GBYSangamo Therapeutics, Inc.
$9.0M
ASMBAssembly Biosciences, Inc.
$7.9M
TPIVDEURMarker Therapeutics, Inc.
$7.7M
APLSApellis Pharmaceuticals, Inc.
$7.6M
CPRXCatalyst Pharmaceuticals, Inc.
$7.1M
HOOKGBPHOOKIPA Pharma Inc.
$6.7M
Acorda Therapeutics, Inc.
$6.4M
Dermira, Inc.
$5.8M
XBITXbiotech Inc.
$5.5M
BDQMAlbireo Pharma, Inc.
$5.0M
VSAREURAravive, Inc.
$5.0M
MISTMilestone Pharmaceuticals Inc.
$5.0M
ORTXUSDOrchard Therapeutics plc
$4.8M
HALOHalozyme Therapeutics, Inc.
$4.7M
NXTCNextCure, Inc.
$4.6M
IFRXInflarx N.V.
$4.4M
ANABAnaptysBio, Inc.
$4.0M
Achillion Pharmaceuticals, Inc.
$3.9M
GLPGGalapagos NV
$3.8M
bluebird bio, Inc.
$3.7M
NGMUSDNGM Biopharmaceuticals, Inc.
$3.5M
MIRMMirum Pharmaceuticals, Inc.
$3.4M
XLRNAcceleron Pharma Inc.
$3.3M
Menlo Therapeutics Inc.
$3.1M
Harpoon Therapeutics, Inc.
$2.9M
VKTXViking Therapeutics, Inc.
$2.9M
Abeona Therapeutics Inc.
$2.9M
GTHXEURG1 Therapeutics, Inc.
$2.9M
Dova Pharmaceuticals, Inc.
$2.9M
Bellicum Pharmaceuticals, Inc.
$2.8M
YMABUSDY-mAbs Therapeutics, Inc.
$2.7M
CRNXCrinetics Pharmaceuticals, Inc.
$2.6M
Cyclerion Therapeutics, Inc.
$2.5M
Spring Bank Pharmaceuticals, Inc.
$2.1M
AUTLAutolus Therapeutics plc
$1.9M
IDYAIDEAYA Biosciences, Inc.
$1.8M
NTLAIntellia Therapeutics, Inc.
$1.7M
Molecular Templates, Inc.
$1.7M
Forty Seven, Inc.
$1.6M
Foamix Pharmaceuticals Ltd.
$1.5M
CTMXCytomX Therapeutics, Inc.
$1.4M
CCXIEURChemoCentryx, Inc.
$1.4M
FLGTFulgent Genetics, Inc.
$1.3M
MTNBEURMatinas BioPharma Holdings, Inc.
$1.3M
LPTXEURLeap Therapeutics, Inc.
$1.1M
RCUSArcus Biosciences, Inc.
$1.1M
GLMDGalmed Pharmaceuticals Ltd.
$1.0M
Adamas Pharmaceuticals, Inc.
$883K
Constellation Pharmaceuticals, Inc.
$861K
Page 1 of 2Next